Posted by Michael Wonder on 17 Jan 2024
Launch and post-launch prices of injectable cancer drugs in the US: clinical benefit, innovation, epidemiology and competition
17 January 2024 - We aimed to identify and quantify factors associated with launch prices and post-launch price changes of injectable cancer drugs in the US from 2005 to 2023.
All anti-cancer drugs with US FDA approval between 2000 and 2022 were identified in the Drugs@FDA database.
